v3.26.3
Consolidated Statements of Assets and Liabilities - USD ($)
$ in Thousands
Sep. 30, 2026
Dec. 31, 2025
Assets    
Fair Value $ 15,095,927 [1],[2] $ 16,470,893 [3],[4]
Cash (restricted cash of $65,227 and $47,448, respectively) 371,361 558,703
Foreign cash (cost of $1,836 and $9,722, respectively) 1,814 9,839
Interest and dividend receivable 94,777 104,576
Prepaid expenses and other assets 40,552 15,508
Total Assets 15,636,304 17,186,365
Liabilities    
Debt (net of unamortized debt issuance costs of $91,962 and $93,186, respectively) 8,134,655 9,300,076
Distribution payable 151,909 184,877
Management fee payable 55,963 63,145
Incentive fee payable 34,371 38,899
Payable for investments purchased 51,315 0
Accrued expenses and other liabilities 188,252 189,517
Total Liabilities 8,621,402 9,789,086
Commitments and contingencies (Note 8)
Net Assets    
Common shares $0.01 par value, 1,000,000,000 shares authorized; 490,029,636 and 499,448,499 shares issued and outstanding, respectively 4,900 4,994
Additional paid-in-capital 7,406,868 7,512,234
Accumulated undistributed (overdistributed) earnings (396,866) (119,949)
Total Net Assets 7,014,902 7,397,279
Total Liabilities and Net Assets $ 15,636,304 $ 17,186,365
Net Asset Value Per Share (in usd per share) $ 14.32 $ 14.81
Affiliated entity    
Assets    
Receivable from a controlled affiliate $ 31,873 $ 26,846
Liabilities    
Payables to affiliates 4,937 12,572
Non-controlled, non-affiliated investments    
Assets    
Fair Value 12,588,183 13,995,055
Non-controlled, affiliated investments    
Assets    
Fair Value 119,861 114,192
Controlled, affiliated investments    
Assets    
Fair Value $ 2,387,883 $ 2,361,646
[1] Certain portfolio company investments are subject to contractual restrictions on sales. Refer to footnote 30 for additional information on the Company’s restricted securities.
[2] Unless otherwise indicated, the Company’s portfolio companies are pledged as collateral supporting the amounts outstanding under the Revolving Credit Facility, SPV Asset Facilities and CLOs. See “Note 5 — Debt.”
[3] Certain portfolio company investments are subject to contractual restrictions on sales. Refer to footnote 30 for additional information on the Company’s restricted securities.
[4] Unless otherwise indicated, the Company’s portfolio companies are pledged as collateral supporting the amounts outstanding under the Revolving Credit Facility, SPV Asset Facilities and CLOs. See “Note 5 — Debt.”